Elevance Reports Caution, But Better News Than United
Elevance Health reported 2025 financial news today and its status is better than imploding UnitedHealth Group. That led to a recovery to some degree in its stock price today.
Elevance beat The Street on profit in Q4 2025 but missed on revenue. The company reported $547 million in profit for Q4, up from $418 million in Q4 2024. However, its $49.3 billion in Q4 revenue fell short. It did have almost 10% growth year over year.
For the full year, Elevance Health brought in $197.6 billion in revenue, up 12.8% from 2024’s $175.2 billion. Profits were down by 5.3% compared to 2024, decreasing from $6 billion to $5.7 billion.
Elevance did report that it will see declining revenue in 2026, though. And profit could be constrained as well. This is tied to shedding of membership to right the financial ship as well as governmental impacts in Medicaid and the Exchanges. The insurer also had elevated utilization and medical costs, with a medical loss ratio of 93.5% in Q4.
Its small but growing Carelon services unit had a good year, with operating revenues of $18.7 billion in Q4 2025, up 27% year over year.
Elevance expects to make a return to 12% growth in earnings per share in 2027.
Elevance expects its Medicare Advantage (MA) membership to drop about 18% or about 400,000. Medicaid rolls will drop as well. Medicaid enrollees are also expected to be more adverse.
Additional articles: https://www.fiercehealthcare.com/payers/elevance-health-beats-profit-misses-revenue-mixed-q4 and https://www.healthcaredive.com/news/elevance-2025-results-2026-outlook-lower/810680/ and https://www.beckerspayer.com/financial/elevance-posts-5-7b-profit-in-2025/
(Some articles may require a subscription.)
#healthplans #margins #elevancehealth #medicareadvantage #medicaid
https://www.modernhealthcare.com/insurance/mh-mied-elevance-health-quarter-bolstered-carelon
